Skip to main content

How Stem Cell Banking Fits Into a Cash-Pay Practice Model in 2026

How stem cell banking fits into a cash-pay practice model in 2026

For physicians already working in a cash-pay or hybrid model, stem cell banking adds a compliant service line that requires no insurance billing, no new equipment, and no additional laboratory infrastructure. The harvest is a 30-minute outpatient procedure under local anesthesia. L2 Bio handles all cell processing and storage. Save My Fat routes patients in […]

The Regenerative Medicine Market in 2026: What Physicians Need to Know Before Deciding

The regenerative medicine market in 2026: what physicians need to know before deciding

Regenerative medicine is no longer a fringe category. The adipose-derived stem cell market is growing at a documented 15% annually, the FDA approved its first mesenchymal stem cell product at the end of 2024, and more than 400 clinical trials involving adipose-derived cells are actively recruiting worldwide. For physicians considering whether to add stem cell […]

What Is Adipose Tissue Banking and Why Are Physicians Adding It to Their Practices?

What is adipose tissue banking and why are physicians adding it to their practices?

Adipose tissue banking is a compliant, cash-pay service that allows patients to preserve their own fat-derived stem cells today for potential future use in FDA-regulated pathways. For physicians, it represents a turnkey addition to an existing practice: a 30-minute harvest procedure, a fully managed lab partnership, and a patient referral model that brings qualified patients […]

Why Patients Are Asking Their Doctors About Stem Cell Banking Right Now

Why patients are asking their doctors about stem cell banking right now

Patients across specialties, including orthopedics, aesthetics, functional medicine, and primary care, are arriving with specific questions about adipose-derived stem cell banking that most physicians were not trained to answer. The underlying demand is not a social media blip. It is being driven by a documented inflection point in regenerative medicine: the FDA’s first approval of […]

What Is 21 CFR Part 1271 and Why It Governs Your Tissue Storage

What is 21 cfr part 1271 and why it governs your tissue storage

Twenty-one CFR Part 1271 is the core FDA regulation that establishes safety and quality rules for human cells, tissues, and cellular and tissue-based products, a category that includes banked adipose tissue. The citation looks like legal code, and in a technical sense it is, but its requirements have very real consequences for how tissue is […]

How to Compare Adipose Tissue Banking Services: A Patient Evaluation Framework

How to compare adipose tissue banking services: a patient evaluation framework

The adipose tissue banking market has grown substantially in recent years, and the services available today vary widely in their regulatory standing, scientific rigor, and honest communication with patients. This article provides a five-category evaluation framework that any patient can apply to any tissue banking service before committing, regardless of which service they are considering. […]

What Questions Should You Ask Before Banking Your Tissue?

What questions should you ask before banking your tissue?

Choosing an adipose tissue banking service is a significant financial and medical decision, and not all services operate at the same level of regulatory compliance, scientific rigor, or transparency. This guide provides a practical checklist of the specific questions every patient should ask before committing to any tissue banking service, and explains what a strong, […]

What Does “Intact Adipose Tissue” Mean and Why Does It Matter Regulatorily?

What does "intact adipose tissue" mean and why does it matter regulatorily?

If you have been researching adipose tissue banking, you have probably come across terms like “intact tissue,” “minimal manipulation,” and “SVF” used in ways that sound important but are never quite explained. These are not just technical phrases. They describe a regulatory distinction with direct legal consequences under federal law, and the choice a banking […]